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Abstract.  Transforming growth factor beta (TGF-13) is 
a  polypeptide growth factor that affects the accumula- 
tion of extracellular matrix by many cell types. We 
have examined the ability of mouse mammary epithe- 
lial (NMuMG) cells to respond to TGF-13 and assessed 
the effect of the growth factor on the expression of 
their cell surface heparan sulfate/chondroitin sulfate 
hybrid proteoglycan. NMuMG cells respond max- 
imally to 3 ng/ml TGF-~ and the response is consis- 
tent with occupancy of the type III receptor.  However, 
cells that are polarized, as shown by sequestration of 
the cell surface PG at their basolateral surfaces, must 
have the growth factor supplied to that site for maxi- 
mal response.  Immunological quantification of pro- 
teoglycan core protein on treated cells suggests that the 
cells have an unchanging number of this proteoglycan 
at their cell surface. Nonetheless, metabolic labeling 
with radiosulfate shows a  •2.5-fold  increase in 35SO4- 
glycosaminoglycans in this proteoglycan fraction, 
defined either by its lipophilic, antigenic, or cell sur- 
face properties.  Kinetic studies indicate that the en- 
hanced radiolabeling is due to augmented synthesis, 
rather than slower degradation. Analysis of the glycos- 
aminoglycan composition of the proteoglycan shows an 
increased amount of chondroitin sulfate, suggesting 
that the increased labeling per cell may be attributed 
to an augmented synthesis of chondroitin sulfate gly- 
cosaminoglycan on the core protein that also bears 
heparan sulfate, thus altering the proportions of these 
two glycosaminoglycans on this hybrid proteoglycan. 
We conclude that TGF-13 may affect NMuMG cell be- 
havior by altering the structure and thus the activity of 
this proteoglycan. 
T 
RANSFORraINO growth  factor  beta  (TGF-13)  t  is  a 
25-kD  polypeptide dimer found in  serum and pro- 
duced in vitro and in vivo by cells from connective tis- 
sue,  epithelia, and the immune system (reviewed  by Mas- 
sagud,  1987; Sporn et al.,  1987).  The monomer can be of 
two types, termed 13l or f12, and homodimers of these often, 
but not always, have similar effects. TGF-13 binds to at least 
three cell surface receptors (Cheifetz et al.,  1987; Segarini 
et al., 1987) and elicits changes in the behavior of different 
cell types, most notably altered cell proliferation and dif- 
ferentiation. Its effects appear similar in vivo, where, for ex- 
ample, it prevents the outgrowth of proliferating mammary 
end buds (Silberstein and Daniels, 1987).  The mechanisms 
whereby the factor's effects are produced are not known, but 
have attracted considerable attention as being central to an 
understanding of normal organ development, wound healing, 
and tumorigenesis. 
Although seemingly unrelated to soluble growth factors, 
cell-extracellular matrix (ECM) interactions also influence 
cell behavior, affecting cell adhesion and motility, growth, 
1. Abbreviations  used in this paper:  CM-PBS,  calcium- and magnesium- 
containing phosphate-buffered  saline; CMF-PBS, calcium- and magnesium- 
free PBS; ECM, extracellular  matrix; FN, fibronectin; GAG, glycosamino- 
glycan;  PG,  proteoglycan;  TGF-13, transforming  growth  factor  (type  ~); 
TUT, Tris/Urea/Triton. 
and differentiation (Wicha et  al.,  1982;  Haeuptle et al., 
1983; Blum et al., 1987). Interactions with the ECM involve 
a variety of matrix receptors, several of which, e.g., laminin 
receptor,  integrins, cell surface proteoglycan (PG), have been 
implicated in binding the cytoskeleton (Brown et al.,  1983; 
Woods et al., 1985; Tamkun et al., 1986;  Rapraeger et al., 
1986).  These  receptors  are believed to  influence cell be- 
havior via  translation of matrix  support  into cytoskeletal 
organization and cell shape. The degree to which these re- 
ceptors translate ligand occupancy directly into other cyto- 
plasmic responses remains unknown. 
Treatment of cultured cells with TGF-I3 affects matrix ac- 
cumulation. Many cells of mesenchymal and epithelial ori- 
gin whose proliferation and differentiation are affected by 
TGF-13 show elevated expression of fibronectin (FN), colla- 
gens and other cell-adhesion proteins (Ignotz and Massagud, 
1986),  apparently via regulation of mRNA levels (Ignotz et 
al., 1987). Chondroitin sulfate PG synthesis is also reported 
to be affected. Human smooth muscle cells (Chen et al., 
1987)  respond to TGF-13 with increased amounts of chon- 
droitin sulfate PGs in the cell layer and culture medium. 
Similarly, a variety of cell lines, including mink lung epi- 
thelial cells, show increased chondroitin sulfate PG in the 
ECM and culture medium in response to TGF-13 (Bassols and 
Massagud,  1988). 
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with TGF-I3 show an enhanced expression of integrin, an FN 
receptor, via regulation at pretranslational and posttransla- 
tional processing steps (Ignotz and Massagu6, 1987).  Thus, 
the growth factor has the potential to affect cell-matrix inter- 
actions not only by altering matrix accumulation, but also by 
changing the expression of receptors for the matrix. 
Cell surface PGs are involved in matrix recognition. Cell 
surface PGs bearing heparan sulfate bind a variety of matrix 
components, localize to matrix-rich sites of cell adhesion and 
colocalize with the intracellular cytoskeleton (H66k et al., 
1984; Lark and Culp, 1984; Woods et al., 1984,  1985; Rap- 
raeger et al.,  1986).  A direct role for heparan sulfate PG in 
growth  control  has  also  been  proposed  (Ishihara  et  al., 
1987).  We have studied a cell surface PG of mouse mam- 
mary epithelial cells. This PG (a) is an integral membrane 
protein (Rapraeger and Bernfield, 1983),  (b) is localized as 
a basolateral antigen to the site of matrix accumulation of 
polarized epithelial cells (Rapraeger et al.,  1986),  (c) con- 
tains primarily heparan sulfate in addition to a minor amount 
of chondroitin sulfate glycosaminoglycan (GAG) (David and 
Van den Berghe,  1985;  Rapraeger et al.,  1985),  (d) binds 
matrix components, including FN (Saunders and Bernfield, 
1988),  interstitial collagens (Koda et al.,  1985) and throm- 
bospondin (Sun, X., D. Mosher, and A. Rapraeger, unpub- 
lished results), primarily via its heparan sulfate chains, and 
(e) interacts with the cytoskeleton (Rapraeger et al.,  1986). 
This report examines the PG after culture in TGF-I~ to better 
understand the controls imposed on its cell surface expression. 
Materials and Methods 
Cell Culture and Radiolabeling 
NMuMG  mouse mammary epithelial cells (passages 13-25)  were main- 
tained in bicarbonate-buffered DME (Gibco Laboratories, Grand Island, 
NY) containing 10%  FBS (Tissue Culture Biological, Tulare,  CA) as de- 
scribed  previously  (David  and  Bernfield,  1979).  Cells  were  plated  at 
10-25 % of confluent density on tissue culture plastic dishes (Falcon Lab- 
ware, Oxnard, CA) and used the next day for assessment of sparse cultures 
or cultured for 3-4 d for assessment of  newly confluent cultures. Cells were 
also plated at  100%  of confluence on plastic dishes or,  for Fig. 3,  filter 
chambers (Transwells,  24  mm,  0.4  p.m,  No.  3412;  Costar,  Cambridge, 
MA), and cultured for a week for assessment  ofpostconfluent  cultures. Cul- 
tures were radiolabeled for up to 48 h in low sulfate medium (David and 
Bernfield,  1979)  containing 20-100  ~tCi/ml  35SO4 (ICN Radiochemicals, 
Irvine, CA). Cell morphology was recorded on Kodak plus-X 35-mm film 
using a Leitz inverted phase microscope. 
TGF-[3 Isolation  and Purification 
Human  "I'GF-I3~ was  either kindly  donated by  Dr.  Lynn Allen-Hoffman 
(Department of Medicine, University of Wisconsin, Madison, WI) after 
isolation from outdated human platelets and purification as described by As- 
soian et al., (1983)  or obtained from R &  D Systems, Inc.  (Minneapolis, 
MN). Lyophilized aliquots were suspended in 4 mM HC1 containing 1 mg/ 
ml BSA and dilutexi immediately in culture medium or flash-frozen  in liquid 
nitrogen and stored at  -70°C. 
PG Isolation  and Purification 
Isolation from Monolayers of NMuMG Cells. After a 24-h incubation in 
radiosulfate with or without TGF-I3, the culture medium was removed and 
the cells recovered by  scraping into calcium- and magnesium-free PBS 
(CMF-PBS) containing 0.5 mM EDTA and centrifuging (200 g). The super- 
natant containing extracellular PG was saved and the cells were washed by 
resuspension in CMF-PBS. The cells were either (a) extracted directly in 
4 M guanidinium chloride containing 0.1% Triton X-100 and 10 mM Tris- 
HC1 (pH 8.0) for quantification of lipophilic PG (see Fig. 4), (b) treated with 
bovine trypsin (Sigma Chemical Co., St. Louis, MO) for removal of cell 
surface PG (Rapraeger and Bern  field, 1985)  followed by extraction of the 
cell residue in 0.1%  Triton X-100,  8 M  urea and  10 mM Tris-HCl (TUT, 
pH 8.0), or (c) initially extracted with isotonic, 1% Triton X-100 at pH 5.0 
(Rapraeger et al., 1986). This latter treatment releases soluble intracellular 
components but leaves the intact cell surface PG anchored in the residue 
of the plasma membrane. Subsequent treatment with the low pH, isotonic 
Triton solution containing 0.5 M KCI releases the cell surface PG from the 
sedimentable residue (Rapraeger et al.,  1986). 
Purification. PG was purified by chromatography on DEAE-Sephacel 
(Pharmacia Fine Chemicals, Piscataway,  N  J). PG dialyzed into 50 mM so- 
dium acetate (pH 4.5), 0.2 M NaCI, 8 M urea, and 1% Triton X-100 was 
applied to a 5-ml packed bed of resin and eluted in the same buffer with 
a 100 ml gradient of NaC1 ranging from 0.2-1.0 M. The eluted PG was dia- 
lyzed into Tris-buffered (50 mM, pH 8.0) isotonic saline, applied to an anti- 
body affinity  column generated by coupling mAb 281, a monoclonal anti- 
body  specific for  the  PG  core  protein,  to  cyanogen bromide-activated 
Sepharose 4B (Pharmacia Fine Chemicals) and eluted in saline containing 
50 mM ethanolamine (pH 11.5) as described by Jalkanen et al. (1985).  The 
pH of the eluted PG was immediately adjusted to neutrality. 
PG Quanttfication 
Total ~sS-iabeled GAG. Radiosulfate-labeled materials  in  CMF-PBS or 
TUT  were  spotted on  cationic  nylon membranes (Zeta-Probe,  Bio-Rad 
Laboratories, Richmond, CA) sandwiched in a dot blot apparatus (Micro- 
fold, V  &  P  Scientific, San Diego, CA). The blot was washed briefly in 
50 mM Tris-HCl (pH 8.0) containing 0.15 M NaCl followed by 95% etha- 
nol, dried and individual dots were assessed  by scintillation counting (Beck- 
man LS-5800 detector) in BioSafe (Research Products International, Mount 
Prospect,  IL)  cocktail.  Spotting of various  dilutions demonstrated that 
retention of PG or GAG by the membrane was >95 % for these experiments, 
whereas inorganic sulfate and sulfated lipids failed to bind (Rapraeger, A., 
unpublished results). 
To quantify chondroitin sulfate in fractions from DEAE-Sephacel chro- 
matography, the column was run in the absence of urea and fractions were 
brought to final concentrations of 100 mM Tris-HCl (pH 8.0), 0.15 M NaCI. 
The samples were then treated at 37°C for 120 min with or without 0.05 
U/ml of chondroitin ABC lyase (ICN Biochemicals, Inc., Irvine, CA) and 
applied to a cationic nylon (Zeta-Probe) dot blot. Disaccharides generated 
by the enzyme digestion fail to bind to the blot and the remaining, intact 
GAG was assessed by scintillation counting. 
Lipophilic PG. Lipophilic PG was quantified by spotting 1:100 dilutions 
of cell extracts on silicone-treated paper (I-PS, Whatman Inc., Clifton, NJ) 
circles (25 ram) pretreated by soaking for several days in 3:1 propanol:water 
followed by overnight soaking in 3 M sodium chloride in 10 mM Tris-HCl 
(pH 8.0) (Jalkanen et al.,  1987).  After 24 h, the filters were washed on a 
vacuum manifold (Hoeffer Scientific Instruments, San Francisco, CA) in 3 
M sodium chloride, 10 mM Tris-HCl (pH 8.0) followed by distilled water. 
Under these conditions, lipophilic PG binds, whereas nonlipophilic PG 
(e.g., the trypsin-released ectodomain or extracellular PGs) fails to bind. 
Core Protein. Relative amounts of core protein were determined by im- 
munostaining PG immobilized on cationic nylon. The soluble PG extracted 
by the low pH Triton-salt method described above was purified by chroma- 
tography  on  DEAE-Sephacel  (>90%  recovery)  followed by  mAb  281 
affinity  chromatography (65-75%  recovery) as described above.  Dilutions 
of antigen in TUT, representing 4,000,  2,000,  and 1,000 dpm, respectively, 
were applied to a dot blot consisting of a sandwich of nitrocellulose overly- 
ing cationic nylon. The PG fails to bind to nitrocellulose, but potentially 
contaminating antibody from the affinity column does bind and is removed. 
The nylon blot is then blocked overnight at 37°C in Tris-buffered (10 mM, 
pH 7.5)  saline containing  10%  FBS, 0.3%  Tween 20 and 0.02%  sodium 
azide. The core protein is detected by incubation for 2 h in saline  +  1% 
FBS containing 50 p.g/ml mAb 281, followed by five washes in saline and 
a second 2-h incubation in saline  +  1%  FBS containing a  1:200 dilution 
of  horseradish  peroxidase-conjugated  goat  anti-rat  IgG  (Jackson  Im- 
munoresearch). After five washes in saline, the blot is developed in 15 ml 
saline containing 0.054 ml 3 % hydrogen peroxide and 3 ml chloronaphthol 
(Sigma Chemical Co.) dissolved at 3 mg/ml in methanol. Binding of correct 
dilutions of PG to the blot was confirmed by scintillation counting after the 
immunological analysis. 
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DNA was quantified as described by Kapuscinski and Skoczylas (1977). 
Briefly,  cell extracts in TUT were diluted 1:100 in DNA assay buffer (50 
mM  sodium phosphate (pH  7.4),  2  M  sodium chloride, 2  mM  EDTA 
[Na2]),  combined with  1 p.g Hoechst 33258  dye (Sigma Chemical Co.), 
and the fluorescence assessed by spectrofluorimetry. Unknowns were com- 
pared  with a  standard curve  generated using calf thymus DNA  (Sigma 
Chemical Co.). 
Indirect Immunofluorescent Microscopy 
Cells on coverslips were fixed directly for 24 h in calcium- and magnesium- 
containing PBS (CM-PBS) containing 4% formaldehyde for visualization 
of apical antigens or permeabilized by extraction in 0.5% Triton X-100, 0.15 
M sodium chloride, 10 mM Tris-HCI (pH 7.5) for 10 min on ice before fixa- 
tion  to  visualize basal  antigens.  Cells  grown on Transwell  filters were 
stained without permeabilization as antibody readily diffuses through the 
filter. Fixed monolayers were incubated for 60 min in CM-PBS containing 
50 mM glycine, then incubated for 60 min at room temperature in CM-PBS 
containing primary and secondary antibodies, respectively, each followed 
by fivefold washes with CM-PBS. The coverslips or filters were mounted 
in Immu-Mount (Shandon) containing 1 mg/ml p-phenylenediamine as a 
free radical scavenger.  Primary antibodies were nonspecific rat serum IgG 
(50 I.tg/ml, Jackson Immunoreseareh), cell surface PG-specific mAb 281 
(rat IgG2^,  50 p.g/ml),  and rabbit anti-FN serum (1:200  dilution; kindly 
supplied by Dr.  Deane Mosher, Department of Medicine, University of 
Wisconsin). Secondary antibodies were TRITC-conjugated goat anti-rat 
IgG and FITC-conjugated goat anti-rabbit IgG (Jackson Immunoresearch, 
Bar  Harbor,  ME).  Slides  were  viewed by  epifluorescence on  a  Nikon 
Micruphot-FX. 
Results 
Polarization-dependent  Response to TGF-[3 
Effect on Cell Density and Morphology. Prior reports indi- 
cate that TGF-13 affects the behavior of  epithelial cells in vitro 
and  in  vivo,  most  notably  inhibiting  their  proliferation 
(Masui et al., 1986; Silberstein and Daniels, 1987). A simi- 
lar inhibition of proliferation was  noted for the  NMuMG 
cells in the presence of 1 ng/ml TOF-I5 (data not shown). 
A  second response of the NMuMG cells to TGF-I5 is in 
their shape, namely, a spreading and elongation of the cell 
in the presence of  the growth factor. Similar effects have been 
noted for other cells (Fanger et al.,  1986). In subconfluent 
cultures, the cells become highly spread and elongated and 
are often aligned in swirls (Fig. 1, A and B). Newly confluent 
cultures incubated in a range of TGF-I3 concentrations for a 
24-h  period remain confluent but display  an  increasingly 
spread morphology with  increasing TGF-I5 concentrations 
(Fig. 1, C-F), with the most spreading occurring at concen- 
trations of 3 and 10 ng/ml. This takes place at the expense 
of other cells in the monolayer which are displaced to the 
medium. In contrast to newly confluent cultures, however, 
cultures maintained at confluence for a  week before treat- 
ment with TGF-13 show little morphological response to the 
growth factor, even at concentrations of 10 ng/ml of TGF-[I 
(compare Fig.  1, G and H) and measurements of total DNA 
find little or no difference in cell number. 
Distribution of Cell Surface laG and FN. Immunolocal- 
ization of cell surface PG and FN demonstrates that the rela- 
tive effects of TGF-I5 on cell morphology are mimicked by 
changes in the distribution or accumulation of these anti- 
gens.  As  shown previously, NMuMG cells in monolayers 
that have reached confluence begin to restrict the cell surface 
PG  to their basolateral  surface (Rapraeger et al.,  1986). 
Staining of fixed, nonpermeabilized monolayers with mAb 
281, a monoclonal antibody specific for the core protein of 
the cell surface PG (Jalkanen et al.,  1985), detects PG only 
on those cells which have yet to completely polarize the anti- 
gen; cells that sequester the PG at their basolateral surfaces 
are also tightly sealed to one another and prevent antibody 
penetration to their lateral and basal sides. 
Newly Confluent Monolayers 
In  monolayers that  have  been  confluent for a  day,  many 
groups of cells display apical PG (Fig. 2 A) but may be bor- 
dered by more highly polarized neighbors that do not stain. 
In similar monolayers that have been extracted with Triton 
X-100 to allow antibody access to the basolateral surface, PG 
is seen on all of the cells (not shown; cf. Rapraeger et al., 
1986) and FN can be detected in a scarce, patchy distribution 
beneath  the  monolayer (Fig.  2  B).  Comparison  of these 
monolayers with those treated for 24 h in TGF-I3 (5 ng/ml) 
illustrates both the cell shape change described above and a 
difference in the distribution of the PG and FN. The cells in 
TGF-15 are more elongated and have greater apical surface 
area than their nontreated counterparts (Fig. 2 C). In addi- 
tion, cells lacking apical PG are only rarely seen; rather, the 
mAb 281 antigen is uniformly distributed over the apical sur- 
face of almost all cells and is localized in greater abundance 
at the cell margins, due somewhat to staining of lateral cell 
surfaces.  Examination  at  high  magnification  shows  that 
staining at the margins of the cells can also be attributed to 
pseudopodia which often overlap onto the apical surface of 
adjacent cells and stain heavily for the PG. This is not seen 
in the nontreated cells. Staining of  permeabilized monolayers 
shows  PG on all basolateral surfaces (not shown) as noted 
for cells cultured in the absence of the growth factor. 
Staining for FN demonstrates an enhanced accumulation 
of this matrix component in the presence of TGF-15 (Fig. 2 
D). The FN is deposited as thick, fibrous strands on the basal 
side of the monolayer, defined by differential focussing at 
high magnification. In contrast to the relatively uniform dis- 
tribution of the cell surface PG, these strands underlie a frac- 
tion of the cells in the monolayer and occasionally encircle 
the basolateral surface of a single cell. 
Postconfluent, Polarized  Monolayers 
Immunostaining  shows  that  TGF-I3 treatment of postcon- 
fluent monolayers on plastic fails to affect the PG distribution 
and FN accumulation of the majority of these cells; the cells 
are polarized with respect to the PG, which is not confined 
to their basolateral cell surface, and do not accumulate a 
noticeable FN matrix (not shown). However, postconfluent 
cells do respond, using FN accumulation as a marker, if cul- 
tured on permeable filters. Cells plated on Transwell filters 
and cultured for 7 d  postconfluence were treated for 24 h 
with TGF-15, which was supplied to either the apical or basal 
medium compartment of these filter chambers. Polarization 
of the NMuMG cells before treatment was confirmed by the 
sequestration of  cell surface PG at the basolateral cell surface 
(not  shown).  As  on  plastic,  the  monolayers  also  appear 
sealed to the penetration of antibodies, as mAb 281 added to 
the apical medium compartment fails to stain the basolateral 
PG (not shown). Cells cultured in the absence of TGF-15 (Fig. 
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mary  epithelial  cell  morphol- 
ogy: dependence on cell density. 
NMuMG cells were plated either 
at 10% of a confluent density and 
allowed to proliferate for 3 d  to 
generate a "subconfluent"  mono- 
layer,  or  at  25%  of confluence 
and  allowed  to  proliferate  3  d 
to  generate  a  "newly  confluent" 
monolayer and for 10 d to gener- 
ate a  "postconfluent" monolayer. 
TGF-13j was then added at vary- 
ing  concentrations  and  the  cell 
morphology was examined follow- 
ing  24  h.  (A)  subconfluent,  no 
TGF-13 ; (B) subconfluent,  10 ng/ 
ml TGF-13 ; (C) newly confluent, 
no TGF-13 ; (D) newly confluent, 
1 ng/ml TGF-13; (E) newly con- 
fluent, 3 ng/ml TGF- I~ ; (F) newly 
confluent,  10 ng/ml TGF-13 ; (G) 
postconfluent,  no  TGF-13; (H) 
postconfluent,  10  ng/ml  TGF-13. 
Bar,  10 ~m. 
3 A) failed to accumulate a FN matrix. The same result was 
obtained if the factor (5  ng/ml) was present only at their api- 
cal surfaces (Fig. 3 B). However, addition of 5 ng/ml TGF-13 
to the basal medium compartment, thus permitting access to 
the basolateral cell surface,  resulted in the accumulation of 
a  FN matrix (Fig.  3  C).  Thus, the ability of polarized cells 
to respond is correlated with the availability of TGF-13 at their 
cell  surfaces,  rather than their  state of polarization  per  se. 
Altered Expression of  CeU Surface laG in TGF-fl 
Effective Concentration of TGF-~. NMuMG mouse mam- 
mary  epithelial  cells  incorporate  35SO4 mostly  into  GAG, 
which on these cells is found primarily as a cell surface PG 
(Rapraeger  and  Bernfield,  1985).  Quantification  of 35SO4- 
labeled cell  surface PG on the NMuMG  cells can be done 
in  several  ways,  each  using  the  distinct  antigenic  and  bio- 
chemical properties of the PG. Initially, lipophilic (e.g., inte- 
gral membrane) PG present in cell extracts was quantified in 
a  hydrophobic  blot assay. 
Radiosulfate  incorporation  into lipophilic  PG was exam- 
ined  in TGF-13~ concentrations  ranging  from 0.3-10  ng/ml. 
These studies used cells just reaching confluence. Additions 
of TGF-13  from 0.3  ng/ml  to  10  ng/ml  caused  more than  a 
twofold  increase  in  incorporation  of 35SO4 into  lipophilic 
PG, with maximal stimulation at 3  ng/ml (Fig.  4).  This in- 
The Journal of Cell Biology, Volume  107, 1988  1962 Figure 2. Localization of cell surface PG and FN in newly confluent cultures following treatment with or without TGF-I~. Newly confluent 
(see legend to Fig.  1) NMuMG monolayers were cultured for 24 h either in the absence (A and B) or the presence (C and D) of TGF-13~ 
(2 ng/ml). Monolayers were then either fixed directly and stained for cell surface PG using mAb 281 (A and C) or extracted with Triton 
X-100 followed by fixation and staining with anti-FN IgG (B and D). The antigens were localized by indirect immunofluorescent micros- 
copy. Prior investigations show that some cells in newly confluent monolayers are polarized with respect to the cell surface PG and therefore 
fail to stain without prior permeabilization, whereas adjacent cells which have not polarized do stain (Rapraeger et al., 1986). The permeabi- 
lized cells in B and D all show basolateral  stain for the cell surface PG (not shown). Bar, 10 Ixm. 
creased accumulation of 35SO4 into lipophilic  PG  suggests 
that cell surface GAG is increased on these ceils.  This was 
corroborated by quantifying  35SO4-1abeled PG released by 
trypsin from the surface of suspended cells. Radiosulfate in- 
corporation into cell surface PG increases with TGF-I~ con- 
centration, paralleling the increase in lipophilic PG. Identi- 
cal  effects were  seen  using  porcine  TGF-132 (not  shown). 
The cell residue, devoid of cell surface PG, shows a 1.4-fold 
increase (data not shown). PG in the culture medium was in- 
creased as well, but interpretation of this was difficult due 
to the variable numbers of floating cells that accumulate dur- 
ing a long labeling period and it was not examined further. 
Cells cultured  1 wk postconfluence on  Transwell  filters 
also showed maximal incorporation of radiosulfate into cell 
surface GAG at 3 ng/ml of TGF-13. This increase ranged from 
2.5- to 3-fold and diminished at 10 ng/ml (data not shown). 
Postconfluent cells cultured on plastic failed to reach maxi- 
mal stimulation even at  10 ng/ml. 
Increased Synthesis of 3sSOc-labeled GAG.  To assess ac- 
cumulation of radiolabeled cell surface PG, cells were pre- 
incubated in TGF-13 (2 ng/ml) for 3 h, then incubated in the 
growth factor and radiosulfate for up to 48 h. To examine ini- 
tial synthesis, several time points were taken during the first 
8 h. Only slight differences in accumulation were seen in the 
culture medium or in the "extracellular PG" compartment, 
defined as the PG remaining in a soluble form when the cells 
are initially scraped and sedimented, in either the presence 
or absence of TGF-13 (not shown).  However, radiolabeled 
GAG appearance at the cell surface (Fig.  5) was enhanced 
in  TGF-13 beginning  2-4  h  after  radiosulfate  addition  (or 
5-7 h of TGF-13 treatment) and continued to increase even up 
to 48 h, where a ~2.5-fold enhancement was seen (Fig. 5). 
The intracellular compartment showed a "~l.4-fold increase 
that remained constant in amount during the labeling period 
and  may  reflect  an  augmented  amount  of  precursor  or 
lysosomal PG (not shown). 
Increased accumulation of radiolabeled PG at the cell sur- 
face may be due to an increased rate of synthesis or to a de- 
creased rate of degradation. However, monitoring the disap- 
pearance of cell surface PG during a chase fails to detect an 
effect of TGF-13 on the PG degradation rate (Fig.  6).  After 
a 24-h label, ceils treated with TGF-13 have accumulated two- 
fold more cell surface label than nontreated cells. Continued 
incubation  of  these  cells  in  the  absence  of  radiosulfate 
demonstrates that the cell surface PG disappears with a half- 
life of ~6 h irrespective of the presence of the growth factor. 
This suggests that the increased accumulation of cell surface 
PG occurs via augmented  synthesis rather than a  lowered 
degradation rate. 
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Figure 4. Quantification of 35SO4-1abeled  cell surface PG vs. TGF- 
13 concentration. Suspended NMuMG cells were extracted after a 
24-h incorporation of 35SO4 in the presence of a range of TGF-13, 
concentrations. DNA content was determined by a Hoechst dye as- 
say and amount of radiolabel in lipophilic PG (e) was assessed 
using  a  hydrophobic blot  assay  as  described  in  Materials and 
Methods. Alternatively, PG at the cell surface of suspended cells 
(o) was released by mild treatment with trypsin and quantified on 
cationic nylon blots. Data are expressed as a ratio of the incorpora- 
tion in TGF-[~ (DPM,  gr) to that in the control (DPMc). 
Figure 3.  Accumulation of FN by cells grown in filter chambers. 
NMuMG cells were grown at confluence for  1 wk on Transwell 
(Costar) filters, then cultured an  additional 24  h  without added 
growth factor (A), with TGF-13~ (5  ng/ml) in the apical medium 
compartment  (B),  or  in  the  basal  medium  compartment  (C). 
Volumes in the apical and basal medium compartments were equal. 
The monolayers were then fixed and stained for indirect immuno- 
fluorescent localization of FN. Bar, 20 lam. 
Increased 35S-labeled GAG Per Core Protein 
Augmented 35SO4 incorporation into PG at the cell surface 
may be due either to more PGs or to more incorporation per 
PG. In an attempt to choose between these possibilities, cell 
surface  PG  from  nontreated  or  TGF-l~-treated  cells  was 
purified and analyzed in an immunodot assay in which PG 
core protein is detected by mAb 281.  This assay uses cationic 
nylon  as  a  blot,  which  quantitatively binds  intact PG  but 
binds denuded core protein only poorly (Rapraeger et al., 
1985). 
Equal  radioactive  amounts  of  purified  35SO4-PG  from 
cells treated with or without TGF-I3 were bound to cationic 
nylon in a series of dilutions (Fig. 7). Immunostaining of the 
blot with mAb 281, to quantify core protein, shows roughly 
twofold less reactivity in the fraction derived from TGF-13- 
treated cells. This estimate suggests about a twofold greater 
incorporation of radiolabel per core protein in the presence 
of TGF-13, which may account for most or all of the increased 
label  seen  on  cell  surfaces  in  the  presence  of the  growth 
factor. 
Increased Proportion of Chondroitin Sulfate GAG 
As the cell surface PG bears not only heparan sulfate but also 
a  minor contribution of chondroitin sulfate, the possibility 
that the proportion of chondroitin sulfate is altered by TGF-[3 
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Figure 5. Time course of radio- 
sulfate incorporation into cell 
surface PG.  Newly confluent 
NMuMG  monolayers  were 
pretreated with TGF-13j (2 ng/ 
ml) for 3 h, then incubated for 
up to 48 h in 2  ng/ml TGF-[3 
and  50  tiCi/ml  35SO4. The 
cell surface PG fraction was 
released by mild treatment of 
suspended  cells with  trypsin 
and  incorporation  of  radio- 
label into GAG was determined 
using the cationic nylon blot 
assay as described in Materi- 
als and Methods. (e, control; 
o,  +  TGF-13) 
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Figure  6.  Loss  of  35SO4-1a- 
beled  cell  surface  PG  from 
cells incubated in the presence 
of  TGF-13. Newly  confluent 
NMuMG monolayers were la- 
beled for 24 h with 50 l~Ci/ml 
35SO4 in the presence or ab- 
sence  of  TGF-[II  (2  ng/ml) 
and then chased without radio- 
sulfate and unchanged TGF-13 
treatment for up to 22 h. Cell 
surface PG was quantified as 
in Fig. 5. The data are normal- 
ized  for differences  in  DNA 
and expressed as dpm remain- 
ing per 35-mm dish. (e, con- 
trol;  o,  +  TGF-13) 
treatment was examined. The ectodomain of the PG was har- 
vested  by  mild  treatment  of 35SO4-1abeled  NMuMG  cells 
with trypsin,  isolated by mAb 281  affinity chromatography, 
and examined on ion exchange chromatography. The trypsin- 
released cell surface PG from TGF-13-treated cells (Fig. 8 B) 
behaves differently when compared to PG derived from non- 
treated cells (Fig. 8 A). It elutes as a broader peak, primarily 
due to a trailing edge. As the binding of the PG to the column 
is via its complement of GAG chains,  with chondroitin  sul- 
fate binding  more strongly than heparan  sulfate,  this  result 
suggests that the PG in the trailing edge of the peak may be 
richer in chondroitin sulfate. This was verified by enzymatic 
analysis.  Treatment of the eluted fractions with chondroitin 
ABC lyase demonstrates that a small proportion of the radio- 
label from nontreated  cells is in chondroitin  sulfate (Fig.  8 
A, stippled area).  The remainder is heparan sulfate, defined 
by its susceptibility to nitrous acid or heparitinase.  Displace- 
ment of the chondroitin sulfate profile to a slightly higher salt 
elution point than the heparan sulfate probably reflects vari- 
ability  in the  actual  number of each  type of chain  per  PG 
molecule,  as reported previously  (Rapraeger  et al.,  1985). 
In response to TGF-13 treatment,  the proportion of radio- 
sulfate  in  chondroitin  sulfate  is  increased.  Although  the 
Figure 7.  Incorporation of radiosul- 
fate per cell surface core protein in 
the presence  or absence of TGF-I3. 
Newly  confluent  NMuMG  mono- 
layers were labeled with radiosulfate 
for 24  h  with  or without treatment 
with TGF-I31 (5 ng/ml) and extracted 
by treatment with low pH Triton/salt 
and  purified  on  DEAE-Sephacel, 
selective for the GAG chains on the 
PG,  followed  by  mAb  281  affinity 
chromatography,  which  is  selective 
for the PG core protein. Serial dilutions of radioactive PG (4,000, 
2,000,  and  1,000 dpm) from cells cultured in the absence (-) or 
presence (+)  of TGF-I~ were spotted on cationic nylon.  Relative 
amounts of PG core protein were then assessed by an antibody-cou- 
pled peroxidase reaction using mAb 281. When compared to the 
nontreated cells, cells treated with TGF-I3 have twice as much label 
in GAG for an equivalent amount of core protein. 
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Figure 8.  Ion exchange chro- 
matography of cell surface PG 
derived  from  cells  treated 
with  or without  TGF-13. The 
35SO4-1abeled ectodomain  of 
the cell surface PG, derived by 
mild trypsin treatment of new- 
ly confluent cells cultured for 
24 h with or without 5 ng/ml 
TGF-I3t, was bound to DEAE- 
Sephacel and eluted in a sodi- 
um chloride gradient ranging 
from 0.2  to  1.0  M.  Radiola- 
beled PG (e) in the fractions 
was assessed by binding to cat- 
ionic nylon blots.  The amount 
and distribution  of chondroi- 
tin  sulfate  in  the  chromato- 
gram (stippled area) was de- 
termined  by  digestion  with 
chondroitin  ABC  lyase.  The 
disaccharides  generated  by 
this digestion fail to bind to the 
blot, whereas the PG still bear- 
ing  heparan  sulfate  chains 
(confirmed by nitrous acid di- 
gestion)  is  quantitatively  re- 
tained (o). 
majority  of the  radiolabel  remains  as  heparan  sulfate,  PG 
molecules eluting at the trailing  edge of the profile contain 
increasing  proportions  of radiolabel  in  chondroitin  sulfate 
(stippled area, Fig.  8 B),  reaching a maximum of ~40 % of 
the radiolabel. 
Discussion 
Transforming growth factor-[I promotes a wide array of cell- 
type specific behavior, including effects on cell proliferation 
and differentiation (reviewed by Massagu6,  1987) and the ac- 
cumulation of ECM components, such as FN and type I col- 
lagen,  and  their  receptors  (Ignotz  and  Massagu6,  1987). 
Therefore, we were interested in studying the effect of TGF-13 
on the expression of cell surface PG by mouse mammary epi- 
thelial cells.  Treatment with TGF-13 causes enhanced radio- 
sulfate  incorporation  into  lipophilic  (integral  membrane) 
PG,  with  an  increase  of ~  2.5-fold  at  3  ng/ml.  The  aug- 
mented radiolabel is (a) displayed as PG at the cell surface, 
(b) due to an increase  in synthesis,  not an alteration  in the 
degradation rate of the PG, and (c) mostly, if not completely, 
attributed to an alteration in the GAG complement of the PG. 
At  a  minimum,  this  alteration  involves  a  change  in  the 
proportion of chondroitin  sulfate to heparan sulfate attached 
to the core protein of this  novel hybrid proteoglycan. 
Effective Concentration of TGF-~ 
The effective concentration of TGF-13 required to maximally 
affect the NMuMG cells is 3 ng/ml.  Similar concentrations 
affect  matrix  accumulation  by  NRK-49F  fibroblasts  and 
other cell lines (Ignotz et al.,  1987;  Bassols and Massagu6, 
1988).  However, a  100-fold lower concentration  affects the 
proliferation  of  normal  human  bronchial  epithelial  cells 
Rasmussen and Rapraeger Proteoglycan Structure Is Altered by TGF-~  1965 (Masui et al.,  1986). A complicating factor in determining 
the effective concentration was the reduction in response of 
confluent monolayers grown on plastic. This appears to be 
temporally related to their polarization of the cell surface PG 
and likely other basolateral membrane proteins. An apparent 
explanation for this  is that the TGF-13 receptor is  present 
largely on the basolateral cell surface, as polarized cells do 
respond to TGF-13 if cultured on permeable filter supports, 
which allow diffusion of the growth factor from the culture 
medium to the basolateral cell surface. Direct identification 
of the receptor will determine whether this is because the 
basolateral surface represents the majority of the cell surface 
area or because the receptor is actually absent from the api- 
cal cell surface. 
TGF-13 binds at least three cell surface receptors (Cheifetz 
et al., 1987; Segarini et al., 1987) and their relative affinities 
and activities when occupied by TGF-13~ or TGF-132 remain 
to be completely understood.  However, augmented chon- 
droitin sulfate PG, FN, and collagen production are report- 
edly mediated via the ~250-300 kD (type III) receptor (Ig- 
notz and  Massagu6,  1987;  Bassols  and  Massagu6,  1988) 
based primarily on the finding (Cheifetz et al.,  1987)  that 
this receptor, in contrast to the other two, binds TGF-13t and 
132 with equal affinities.  As the NMuMG cells deposit FN 
and appear to respond equally to both TGF-13 homodimers, 
this is consistent with a response mediated via the type III 
receptor. Interestingly, during review of this report, the 250- 
kD receptor on Swiss 3T3 cells has been identified as a hep- 
aran  sulfate/chondroitin  sulfate  hybrid  PG  (Segarini  and 
Seyedin, 1988) that binds TGF-13 via its core protein. The 
presence of the type III receptor in NMuMG cells and the 
potential relationship between that receptor and this epithe- 
lial cell surface PG remains to be examined. However, iden- 
tification of this or a  related PG as the responsive TGF-13 
receptor would explain the polarization-dependent response 
of these cells and pose questions regarding changes in its 
structure affecting its activity. 
Alteration of the Cell Surface Proteoglycan 
During TGF-]J Treatment 
The NMuMG cell surface PG is a complex macromolecule 
that bears heparan sulfate GAG and a complement of chon- 
droitin  sulfate GAG,  suggesting  a  regulatory mechanism. 
The effect of TGF-13 on the NMuMG cells may reflect this 
regulation; e.g., promote chondroitin sulfate synthesis on the 
epithelial PG core protein. 
The relative amounts of core protein on treated and non- 
treated cells are similar as determined by mAb 281 recogni- 
tion. Although it is possible that the core protein from TGF-13 
treated cells might not be recognized by the antibody due to 
a change in the attachment of GAG chains, perhaps blocking 
the antigenic site, this is unlikely as the PG is isolated by 
mAb 281 affinity chromatography. This suggests that the ad- 
ditional radiolabel appearing at the cell surface is incorpo- 
rated as more chondroitin sulfate GAG onto the core protein 
that normally contains primarily heparan sulfate. This may 
be regulated either by the addition of more chondroitin sul- 
fate chains, perhaps at the expense of heparan sulfate, or by 
an increase in the size of the chains. The chondroitin sulfate 
and  heparan  sulfate chains  do  appear  longer,  but  not by 
enough to account for the entire increase (Rasmussen,  S., 
and A.  Rapraeger, unpublished observations). 
Whereas this report examines the modification of a hepa- 
ran sulfate cell surface PG by the addition of chondroitin sul- 
fate, the effect of TGF-13 on the synthesis of chondroitin sul- 
fate PGs has been reported by other workers. Chondroitin 
sulfate is increased in the culture medium and cell layer of 
smooth muscle cells (Chen and McKeehan, 1987). Most re- 
cently, Bassols and Massagu6 (1988) have reported increased 
synthesis of chondroitin sulfate PGs in the matrix and culture 
medium of several cell lines,  including mink lung epithe- 
lium.  These  increases  are  several-fold  greater  than  that 
reported here and include augmented core protein synthesis 
as well as an increase in the length of the chondroitin sulfate 
chains. Whether heparan sulfate PG synthesis is refractory 
to TGF-13 in all cells, and whether this explains the absence 
of elevated core protein accumulation in the NMuMG cells 
is not clear. 
Changing  the  kind,  number  or  character  of the  GAG 
chains attached to the core protein of the NMuMG cell sur- 
face PG may have profound effects on its potential function 
as a receptor. Where studied, the binding of matrix compo- 
nents by the PG has been dependent on its GAG chains, pri- 
marily the heparan sulfate chains which bind to interstitial 
collagens (Koda et al.,  1985), FN (Saunders and Bernfield, 
1988), and thrombospondin (Sun, X.,  D.  Mosher, and A. 
Rapraeger, manuscript submitted for publication). A change 
in the number or sulfation of the heparan sulfate chains, or 
a change in the number and orientation of the chondroitin 
sulfate chains may affect this binding,  thereby affecting its 
receptor role. The degree to which the alteration in PG struc- 
ture is involved in the multiple effects of TGF-13 is currently 
being studied. 
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